Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBIT Margin (2016)

Historic EBIT Margin for Tenax Therapeutics (TENX) over the last 4 years, with Q2 2013 value amounting to 4444.87%.

  • Tenax Therapeutics' EBIT Margin fell 189352200.0% to 4444.87% in Q2 2013 from the same period last year, while for Dec 2015 it was 3771409.64%, marking a year-over-year change of. This contributed to the annual value of 84756.52% for FY2024, which is 504481900.0% up from last year.
  • As of Q2 2013, Tenax Therapeutics' EBIT Margin stood at 4444.87%, which was down 189352200.0% from 715.64% recorded in Q1 2013.
  • Tenax Therapeutics' 5-year EBIT Margin high stood at 14490.35% for Q2 2012, and its period low was 250680.02% during Q3 2010.
  • Moreover, its 4-year median value for EBIT Margin was 665.7% (2012), whereas its average is 19265.68%.
  • In the last 5 years, Tenax Therapeutics' EBIT Margin soared by 2000000000bps in 2011 and then plummeted by -189352200bps in 2013.
  • Over the past 4 years, Tenax Therapeutics' EBIT Margin (Quarter) stood at 7582.16% in 2010, then crashed by -128bps to 2158.73% in 2011, then skyrocketed by 94bps to 132.62% in 2012, then crashed by -3251bps to 4444.87% in 2013.
  • Its EBIT Margin was 4444.87% in Q2 2013, compared to 715.64% in Q1 2013 and 132.62% in Q4 2012.